menu

Medical Industry Feature: Urothelial Carcinoma: Case Study on a Patient Who Is Platinum Ineligible

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Urothelial Carcinoma: Case Study on a Patient Who Is Platinum Ineligible

Program Information
Recommended
Urothelial Carcinoma: Case Study on a Patient Who Is Platinum Ineligible
RestartResume
What clues from a urothelial carcinoma patient’s condition might indicate that platinum-based chemotherapy isn’t an option for them?
  • Sponsored by

  • Overview

    Determining if a urothelial carcinoma patient is ineligible for platinum-based chemotherapy isn’t always easy. That’s why Dr. Peter O’Donnell, associate professor of medicine in the Department of Medicine at the University of Chicago, reviews a hypothetical patient case that demonstrates how he comes to that conclusion.

    US-OBD-00060 03/19

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 8/18/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.